The glucagon action parameter, a2, which is a measure of how effective it is in hepatic glucose production, is not significantly different between the CS and T2D subjects and is thus not the likely cause of elevated fasting and post prandial plasma glucose levels. Here, GCG is linked to type 2 diabetes mellitus.